Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

DNA chips: the future of biomarkers.

De Benedetti VM, Biglia N, Sismondi P, De Bortoli M.

Int J Biol Markers. 2000 Jan-Mar;15(1):1-9. Review.

PMID:
10763133
2.

Characterization of ten novel and 13 recurring BRCA1 and BRCA2 germline mutations in Italian breast and/or ovarian carcinoma patients. Mutations in brief no. 178. Online.

De Benedetti VM, Radice P, Pasini B, Stagi L, Pensotti V, Mondini P, Manoukian S, Conti A, Spatti G, Rilke F, Pierotti MA.

Hum Mutat. 1998;12(3):215.

PMID:
10660329
3.

Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis.

Cawley HM, Meltzer SJ, De Benedetti VM, Hollstein MC, Muehlbauer KR, Liang L, Bennett WP, Souza RF, Greenwald BD, Cottrell J, Salabes A, Bartsch H, Trivers GE.

Gastroenterology. 1998 Jul;115(1):19-27.

PMID:
9649454
4.

Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors.

von Brevern MC, Hollstein MC, Cawley HM, De Benedetti VM, Bennett WP, Liang L, He AG, Zhu SM, Tursz T, Janin N, Trivers GE.

Cancer Res. 1996 Nov 1;56(21):4917-21.

5.

Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer.

Trivers GE, De Benedetti VM, Cawley HL, Caron G, Harrington AM, Bennett WP, Jett JR, Colby TV, Tazelaar H, Pairolero P, Miller RD, Harris CC.

Clin Cancer Res. 1996 Oct;2(10):1767-75.

6.

Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.

De Benedetti VM, Radice P, Mondini P, Spatti G, Conti A, Illeni MT, Caligo MA, Cipollini G, Bevilaqua G, Pilotti S, Pierotti MA.

Oncogene. 1996 Sep 19;13(6):1353-7.

PMID:
8808710
7.

p53 mutations in lung cancer following radiation therapy for Hodgkin's disease.

De Benedetti VM, Travis LB, Welsh JA, van Leeuwen FE, Stovall M, Clarke EA, Boice JD Jr, Bennett WP.

Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):93-8.

8.

p53 mutations in hepatocellular carcinoma related to oral contraceptive use.

De Benedetti VM, Welsh JA, Yu MC, Bennett WP.

Carcinogenesis. 1996 Jan;17(1):145-9.

PMID:
8565124
9.

Lung carcinoma and malignant mesothelioma in patients exposed to Thorotrast: incidence, histology and p53 status.

Andersson M, Wallin H, J├Ânsson M, Nielsen LL, Visfeldt J, Vyberg M, Bennett WP, De Benedetti VM, Travis LB, Storm HH.

Int J Cancer. 1995 Nov 3;63(3):330-6.

PMID:
7591226
10.

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.

Guinee DG Jr, Travis WD, Trivers GE, De Benedetti VM, Cawley H, Welsh JA, Bennett WP, Jett J, Colby TV, Tazelaar H, et al.

Carcinogenesis. 1995 May;16(5):993-1002.

PMID:
7767998
11.

p53 is not mutated in hepatocellular carcinomas from Alaska Natives.

De Benedetti VM, Welsh JA, Trivers GE, Harpster A, Parkinson AJ, Lanier AP, McMahon BJ, Bennett WP.

Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb;4(1):79-82.

Supplemental Content

Loading ...
Support Center